Page 26 - Technology Access Pool News Today

Director-Generals opening remarks at One Shared World event Format Good morning, good afternoon and good evening to everyone, and thank you for having me today. As you all know, vaccines offer real hope of bringing the pandemic under control. The development and approval of not one, but several safe and effective vaccines so quickly is an incredible scientific achievement. But the hard truth is that the world’s richest people are benefiting from this achievement, while most of the world’s p...

Manufacturers facing growing pressure to transfer vaccine blueprints to other companies to help increase global production of doses

5 May 2021, 00:01 UTC G7 governments still refusing to waive intellectual property on Covid-19 vaccines, despite widespread public support People’s Vaccine Alliance calls for G7 leaders to support a vaccine patent waiver at today’s foreign and development ministers meeting in London. A supermajority of people in G7 countries believe that governments should ensure pharmaceutical companies share the formulas and technology to their vaccines, according to new polling from the People’s Vaccin...

Morals and the vaccine market May 04,2021 - Last updated at May 04,2021 ITHACA — As the second wave of the COVID-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as Bangladesh, Pakistan, Turkey, the Philippines, Ethiopia and Kenya. There are many reasons f...

AstraZeneca has claimed it does not have enough engineers to help share its vital Covid vaccine technology with other global manufacturers, as other pharmaceutical giants face growing pressure to relinquish their control over the production of the life-saving jabs. Amid a global shortage of supplies, health campaigners have called on the likes of AstraZeneca, Pfizer, Moderna and others to waive their intellectual property (IP) rights and...

Commentary: Glaring vaccine gaps across the world are too big to ignore Toggle share menu Advertisement Commentary: Glaring vaccine gaps across the world are too big to ignore Many hoped the pandemic would end proprietary science and patent-based market monopolies. That hope has since faded, says Kaushik Basu. FILE PHOTO: A health worker prepares a dose of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at the Tecn...

» AstraZeneca has drawn criticism for saying it cant share its vaccine tech with the WHO because it has no engineers available to brief people and train them AstraZeneca has drawn criticism for saying it cant share its vaccine tech with the WHO because it has no engineers available to brief people and train them Zahra TayebMay 3, 2021, 00:30 IST AstraZeneca recently took part in a shareholder Q&A.Reuters/Dado Ruvic AstraZeneca recently said it had no engineers to assist in the transfer of vac...

May 3, 2021 ITHACA, New York – As the second wave of the COVID-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as Bangladesh, Pakistan, Turkey, the Philippines, Ethiopia, and Kenya. There are many reasons for this divide, but uneven access to hea...

AstraZeneca says it cant share its vaccine technology because engineers are unavailable  May 03, 2021, 06:29 AM facebook (Getty Images) The statement by the companys CEO was made during a shareholder Q&A. It has drawn criticism from campaign groups and other industry observers. Health industry observers and social justice groups have criticised recent comments by AstraZenecas CEO about vaccine technology transfer. AstraZeneca has said it cannot share such technolog...

Inequity in access to Covid-19 vaccines abets second wave Kaushik Basu More than one billion vaccine doses have now been administered worldwide, but vast disparities remain. As the second wave of the Covid-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as ...